Zoetis Inc
NYSE:ZTS
Zoetis Inc
NYSE:ZTS
Price:
116.63
USD
-0.07%
Market Closed
Market Cap:
$49.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zoetis Inc
NYSE:ZTS
|
US |
|
C
|
COFCO Sugar Holding Co Ltd
SSE:600737
|
CN |
|
S
|
Shanghai Material Trading Co Ltd
SSE:600822
|
CN |
|
Shenzhen Guangju Energy Co Ltd
SZSE:000096
|
CN |
|
Auto Italia Holdings Ltd
HKEX:720
|
HK |
|
B
|
Beijing Jetsen Technology Co Ltd
SZSE:300182
|
CN |
|
B
|
Botnia Exploration Holding AB (publ)
STO:BOTX
|
SE |
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
|
A
|
APAC Resources Ltd
HKEX:1104
|
HK |
|
KH Neochem Co Ltd
TSE:4189
|
JP |
|
Alexander's Inc
NYSE:ALX
|
US |
|
Central Asia Metals PLC
LSE:CAML
|
UK |
|
Ujjivan Small Finance Bank Ltd
NSE:UJJIVANSFB
|
IN |
|
Z
|
Ziel Home Furnishing Technology Co Ltd
SZSE:301376
|
CN |
|
K
|
K2 F&B Holdings Ltd
HKEX:2108
|
SG |
|
F
|
Franchetti SpA
MIL:FCH
|
IT |
|
I
|
Italtile Ltd
JSE:ITE
|
ZA |
|
H
|
Hangzhou Advance Gearbox Group Co Ltd
SSE:601177
|
CN |
|
Grocery Outlet Holding Corp
NASDAQ:GO
|
US |
Multiples-Based Value
The Multiples-Based Value of one
ZTS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 116.63 USD,
Zoetis Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZTS Multiples-Based Value
LOCKED
Multiples Across Competitors
ZTS Competitors Multiples
Zoetis Inc Competitors
Zoetis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Zoetis Inc
NYSE:ZTS
|
49.6B USD | 5.2 | 18.5 | 13.2 | 15 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
